1-3 of 3
Montserrat Arnan
Close
Sort by
Journal Articles

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1 -mutated AML

Clinical Trials & Observations
Stéphane de Botton, Pierre Fenaux, Karen Yee, Christian Récher, Andrew H. Wei, Pau Montesinos, David C. Taussig, Arnaud Pigneux, Thorsten Braun, Antonio Curti, Carolyn Grove, Brian A. Jonas, Asim Khwaja, Ollivier Legrand, Pierre Peterlin, Montserrat Arnan, William Blum, Daniela Cilloni, Devendra K. Hiwase, Joseph G. Jurcic, Jürgen Krauter, Xavier Thomas, Justin M. Watts, Jay Yang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Emma Barrett, Jorge Cortes
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3117–3127.
https://doi.org/10.1182/bloodadvances.2022009411
Published: 2023
Includes: Supplemental data
Journal Articles

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Alex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Montserrat Arnan, Mar Tormo, Susana Vives, María Paz Queipo de Llano, Rosa Coll, David Gallardo, Ferran Vall-Llovera, Lourdes Escoda, Antonio Garcia-Guiñon, Olga Salamero, Antònia Sampol, Brayan M. Merchan, Joan Bargay, Sandra Castaño-Díez, Daniel Esteban, Aina Oliver-Caldés, Andrea Rivero, Pablo Mozas, Mònica López-Guerra, Marta Pratcorona, Lurdes Zamora, Dolors Costa, Maria Rozman, Josep F. Nomdedéu, Dolors Colomer, Salut Brunet, Jorge Sierra, Jordi Esteve,
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1193–1206.
https://doi.org/10.1182/bloodadvances.2021005585
Published: 2022
Includes: Supplemental data
Journal Articles

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

Clinical Trials & Observations
Guadalupe Oñate, Alex Bataller, Ana Garrido, Montserrat Hoyos, Montserrat Arnan, Susana Vives, Rosa Coll, Mar Tormo, Antònia Sampol, Lourdes Escoda, Olga Salamero, Antoni Garcia, Joan Bargay, Alba Aljarilla, Josep F. Nomdedeu, Jordi Esteve, Jorge Sierra, Marta Pratcorona
Journal: Blood Advances
Blood Adv (2022) 6 (3): 882–890.
https://doi.org/10.1182/bloodadvances.2020004136
Published: 2022
Includes: Supplemental data